Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

July 03, 2024

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

June 26, 2024

5 things to know before the stock market opens

June 25, 2024

Novo Nordisk's Wegovy weight loss drug approved in China

June 25, 2024

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

June 24, 2024

Weight loss drug contender Zealand Pharma jumps 23% on trial results

June 21, 2024

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

June 18, 2024

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

June 17, 2024

European stocks set for muted open after European Central Bank cut

June 07, 2024

Why half of all workers may struggle to get weight-loss drug health insurance coverage

May 30, 2024

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages

May 29, 2024

Cramer's Lightning Round: Apple is a buy

May 28, 2024

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024

How digital health companies are capitalizing on the GLP-1 boom

May 25, 2024

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

May 21, 2024

AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines

May 21, 2024

Hims & Hers Health adds compounded GLP-1 injections to weight loss program

May 20, 2024

Roche says weight loss drug shows promising results in early trial

May 16, 2024

Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says

May 14, 2024

People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says

May 14, 2024

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

May 07, 2024

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

May 07, 2024

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

May 03, 2024

Amgen scraps experimental weight loss pill, moves forward with injection

May 02, 2024

Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double

May 02, 2024

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

April 30, 2024

Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.

April 24, 2024

More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says

April 24, 2024

Most people on weight loss drugs are spending less on restaurants and takeout, survey says

April 20, 2024

Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says

April 17, 2024

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.